Spiking SARS-CoV-2 antiviral immunity in the respiratory tract is a research paper published in Trends in Immunology (2022). On theSindex it has a DataRank of 0.292. It has been cited 6 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.292
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases
Grant: U19 AI142737
National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases
Grant: RO1 AI152476
National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases
Grant: RO1 AI153413
NIAID NIH HHS
Grant: R01 AI152476
NIAID NIH HHS
Grant: R01 AI153413
National Institutes of Health
Grant: 5U19AI142737-03
Tissue and organ specific human B cell immunity
National Institutes of Health
Grant: 5R01AI152476-03
Molecular Analysis and Lineage Tracing of Influenza-Specific, Lung-Resident Memory B Cells
National Institutes of Health
Grant: 5R01AI153413-02
Protective functions of influenza-specific lung-resident memory B cells
National Institutes of Health
FWCI
0.39
Citation Percentile
0.6%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals